tiprankstipranks
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market
Holding GMAB?
Track your performance easily

Genmab (GMAB) Financial Statements

585 Followers

Genmab Financial Overview

Genmab's market cap is currently ―. The company's EPS TTM is $1.045; its P/E ratio is ―; Genmab is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 4.09B$ 3.16B$ 2.12B
Gross Profit-----
EBIT--$ 3.28B$ 2.69B$ 616.00M
EBITDA--$ 3.28B$ 2.69B$ 616.00M
Net Income Common Stockholders--$ 2.58B$ 1.89B$ 465.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 28.14B$ 22.32B$ 23.79B$ 21.61B$ 19.99B
Total Assets$ 35.29B$ 30.12B$ 30.69B$ 27.48B$ 24.91B
Total Debt$ 770.00M$ 597.00M$ 629.00M$ 634.00M$ 416.00M
Net Debt$ -27.36B$ -21.73B$ -23.16B$ -20.98B$ -19.57B
Total Liabilities$ 3.68B$ 2.84B$ 4.03B$ 2.99B$ 2.19B
Stockholders Equity$ 31.61B$ 27.28B$ 26.66B$ 24.48B$ 22.72B
Cash Flow-
Free Cash Flow--$ 1.89B$ 891.00M$ 530.00M
Operating Cash Flow--$ 1.97B$ 959.00M$ 587.00M
Investing Cash Flow--$ -1.38B$ -576.00M$ -667.00M
Financing Cash Flow--$ -642.00M$ -214.00M$ -64.00M
Currency in USD

Genmab Earnings and Revenue History

Genmab Debt to Assets

Genmab Cash Flow

Genmab Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis